YOLFTbeta
China Resources Boya Bio pharmaceutical Group Co Ltd

China Resources Boya Bio pharmaceutical Group Co Ltd

300294 · SHE · Healthcare / Biotechnology

13.31CNY-0.36 (-2.63%)

Price History

Full chart

Market Stats

Previous Close13.67
Open13.65
Day Range13.28 – 13.69
52-Week Range13.64 – 25.52
Volume5.29M
Market Cap7.53B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.13
Dividend Yield1.49%
Beta0.41
50-Day Avg14.95
200-Day Avg18.15

About

China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the research, development, production, and sale of blood products in China. It offers blood products, such as human serum albumin; human, intravenous, freeze-dried intravenous, hepatitis B, tetanus, and rabies immunoglobulin; and human fibrinogen, prothrombin complex, and coagulation factor VIII. The company also provides compound bone peptide, oxytocin, heparin sodium injection, posterior pituitary, and carboprost tromethamine injection. In addition, it engages in research, development, production, and sales of anti-infective, diabetes, and cardiovascular drugs. The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co.,Ltd. The company was founded in 1993 and is based in Fuzhou, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Yuxuan Pan
  • Employees1.95K
  • HeadquartersNo. 333, Huiquan Road, Fuzhou, China, 344000, China
  • Websitehttps://www.china-boya.com

Leadership

  • Mr. Yuxuan PanCFO, Board Secretary & Director · b. 1984
  • Mr. Qingsong LinVice President · b. 1982
  • Mr. Shousun IiVice President · b. 1977
  • Mr. Shuanhong ZhangVice President · b. 1982
  • Zi He WangAccounting Supervisor

Financials

Income Statement

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue90.17M119.72M141.82M195.23M227.26M245.28M437.79M543.18M946.60M1.39B2.39B2.91B2.51B2.65B2.76B2.65B1.73B2.05B
Growth (%)-+32.78%+18.46%+37.65%+16.41%+7.93%+78.49%+24.07%+74.27%+46.88%+71.72%+21.83%-13.60%+5.47%+4.08%-3.87%-34.58%+18.15%
Cost of Revenue29.95M38.19M41.73M70.69M93.19M106.27M167.59M194.95M349.89M421.10M863.30M1.13B1.06B1.19B1.25B1.26B615.97M1.11B
Gross Profit60.22M81.54M100.10M126.03M134.07M139.00M270.20M348.23M596.71M969.29M1.52B1.78B1.46B1.46B1.50B1.39B1.12B936.88M
Gross Margin66.79%68.10%70.58%64.56%59.00%56.67%61.72%64.11%63.04%69.71%63.84%61.29%58.01%55.21%54.52%52.54%64.50%45.71%
Operating Expense26.33M39.01M46.52M51.25M51.52M45.17M140.81M201.63M271.14M539.93M959.69M1.27B1.13B1.02B971.84M1.04B641.68M667.21M
Operating Income33.90M42.53M53.58M74.78M82.56M93.83M129.39M146.60M325.57M429.36M564.54M514.12M331.46M443.06M532.18M355.23M477.25M269.66M
Operating Margin37.59%35.52%37.78%38.30%36.33%38.26%29.56%26.99%34.39%30.88%23.65%17.67%13.19%16.72%19.29%13.39%27.51%13.16%
EBITDA37.76M52.85M82.12M96.89M107.34M95.86M150.00M192.08M359.16M449.37M608.32M605.49M411.52M510.65M600.38M624.38M519.84M434.36M
EBITDA Margin41.88%44.14%57.90%49.63%47.23%39.08%34.26%35.36%37.94%32.32%25.48%20.82%16.38%19.27%21.76%23.54%29.96%21.19%
Net Income10.71M31.48M49.98M65.23M75.15M82.40M104.18M151.80M272.04M356.59M469.17M426.15M260.06M344.53M432.20M237.47M396.99M112.70M
Net Income Margin11.88%26.29%35.24%33.41%33.07%33.60%23.80%27.95%28.74%25.65%19.65%14.65%10.35%13.00%15.67%8.95%22.88%5.50%
R&D-6.81M9.08M8.87M11.06M14.22M16.64M23.89M42.41M34.53M45.06M92.76M90.72M59.29M49.58M67.70M71.35M50.74M
R&D as % of Total Revenue-5.69%6.40%4.54%4.86%5.80%3.80%4.40%4.48%2.48%1.89%3.19%3.61%2.24%1.80%2.55%4.11%2.48%
Interest Expense4.21M2.72M5.75M3.66M1.07M73.42K287.02K1.34M472.06K1.92M24.24M31.32M21.87M10.53M922.07K800.54K1.09M1.56M
Interest Expense % of Total Revenue4.67%2.27%4.05%1.88%0.47%0.03%0.07%0.25%0.05%0.14%1.02%1.08%0.87%0.40%0.03%0.03%0.06%0.08%

Balance Sheet

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets149.28M316.43M295.23M331.15M777.41M1.00B1.02B2.19B2.42B3.67B5.07B5.26B5.16B7.62B8.03B7.83B8.40B8.63B
Total Liabilities85.49M151.93M97.79M68.48M25.80M157.85M93.90M280.11M287.30M1.19B1.30B1.27B966.08M701.30M748.35M508.07M913.38M1.16B
Total Equity63.02M164.49M197.44M262.67M751.60M792.11M858.39M1.87B2.09B2.43B3.70B3.91B4.11B6.83B7.19B7.32B7.49B7.44B
Cash2.60M94.07M47.00M78.19M520.73M398.53M345.94M698.44M422.14M502.47M1.19B568.75M753.89M1.58B1.53B1.96B1.30B573.74M
Total Debt42.50M96.50M66.50M40.00M---45.15M22.14M527.14M606.50M623.39M330.39M35.58M35.36M23.55M7.17M332.91M
Net Debt39.90M2.43M19.50M-38.19M-520.73M-398.53M-345.94M-653.29M-400.00M24.67M-586.89M54.64M-423.50M-1.55B-1.50B-1.89B-1.29B-240.82M

Cash Flow

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-51.88M24.77M81.53M92.36M89.11M121.88M147.02M198.76M-23.82M34.90M-114.51M718.58M1.35B596.44M641.73M299.78M116.69M
Investing Cash Flow-46.94M-73.65M-12.25M-18.27M-24.44M-178.21M-134.46M-283.73M-399.20M-369.89M-209.91M-273.10M-128.34M-2.54B-560.22M14.25M-647.53M-735.44M
Financing Cash Flow-30.58M113.24M-59.59M-32.06M374.62M-35.90M-37.90M488.74M-76.83M464.86M847.15M-237.59M-390.46M2.03B-85.01M-236.65M-303.47M-156.07M
Capital Expenditure42.78M55.40M36.65M18.27M24.45M32.90M47.89M159.37M300.09M237.78M113.90M88.61M142.51M68.12M138.41M87.50M197.79M535.31M
Free Cash Flow-42.78M-3.52M-11.88M63.26M67.91M56.21M73.99M-12.36M-101.33M-261.60M-79.00M-203.13M576.07M1.28B458.03M554.23M101.99M-418.62M
Dividends Paid4.36M4.96M22.78M3.66M20.02M37.90M37.90M47.12M55.06M39.56M101.70M65.00M63.89M27.69M75.64M134.90M232.41M156.32M
FCF to OCF--6.79%-47.99%77.59%73.53%63.08%60.71%-8.40%-50.98%1098.42%-226.34%177.38%80.17%94.94%76.79%86.37%34.02%-358.76%
Dividend Paid to FCF-10.18%-140.87%-191.69%5.79%29.47%67.43%51.22%-381.37%-54.34%-15.12%-128.74%-32.00%11.09%2.17%16.51%24.34%227.88%-37.34%

Earnings

Report DateMar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Oct 24, 2014Feb 9, 2015Apr 25, 2015Aug 17, 2015Oct 27, 2015Feb 23, 2016Apr 19, 2016Aug 4, 2016Oct 25, 2016Mar 22, 2017Apr 6, 2017Aug 7, 2017Oct 29, 2017Feb 27, 2018Apr 26, 2018Aug 16, 2018Oct 24, 2018Feb 12, 2019Apr 23, 2019Aug 27, 2019Oct 24, 2019Feb 28, 2020Apr 28, 2020Aug 26, 2020Oct 29, 2020Apr 26, 2021Aug 26, 2021Oct 28, 2021Mar 22, 2022Apr 22, 2022Aug 19, 2022Oct 24, 2022Mar 12, 2023Apr 24, 2023Aug 21, 2023Oct 25, 2023Mar 22, 2024Apr 23, 2024Aug 24, 2024Oct 24, 2024Mar 18, 2025Apr 24, 2025Aug 22, 2025Oct 28, 2025Mar 20, 2026Apr 24, 2026Aug 22, 2026
EPS Estimate------------------0.190.250.190.270.280.310.230.320.320.320.290.380.38--0.370.220.24--------0.360.280.080.330.270.300.170.270.240.240.34--
EPS Actual0.050.050.060.060.050.060.060.070.060.070.080.100.130.070.100.130.100.170.190.220.170.230.170.330.180.280.220.430.210.290.240.260.230.150.140.080.220.290.050.210.340.280.030.340.240.21-0.440.250.260.16-0.070.280.130.09-0.440.060.04
Surprise------------------0.00%-12.00%-10.53%-14.81%-39.29%6.45%-21.74%-12.50%-31.25%34.38%-27.59%-23.68%-36.84%---59.46%-36.36%-66.67%---------33.33%-25.00%-650.00%-24.24%-1.89%-46.67%-141.18%3.70%-45.83%-62.50%-229.41%--
Timing----------Pre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketAfter-hoursPre-marketAfter-hours-After-hours--

Key Statistics & Ratios

Market Cap7.53B
Enterprise Value4.78B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales4.44
Price / Book1.00
EPS-0.13
Book Value14.76
Revenue (TTM)1.69B
Gross Profit (TTM)767.46M
EBITDA198.81M
Profit Margin-3.63%
Operating Margin-1.23%
Return on Equity-0.82%
Return on Assets0.55%
Shares Outstanding504.25M
Shares Float267.13M
Beta0.41
Dividend Yield1.49%
Dividend Rate0.22
Payout Ratio0.00%

Dividends

20261×
0.07May 20, 2026
20252×
0.15Sep 26, 20250.16May 28, 2025
20242×
0.16Oct 25, 20240.30Apr 26, 2024
20231×
0.20Apr 28, 2023
20221×
0.15May 13, 2022
20211×
0.07May 26, 2021
20201×
0.15Jun 19, 2020
20191×
0.15Jun 26, 2019
20181×
0.15Jul 11, 2018
20171×
0.07May 26, 2017
20161×
0.13May 13, 2016
20151×
0.13Apr 7, 2015
20141×
0.11Apr 3, 2014
20131×
0.11Mar 20, 2013
20121×
0.06May 30, 2012

Stock Splits

  • May 26, 201715:10
  • Sep 18, 201520:10
  • Apr 7, 201515:10